3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Other
1
Head & Neck
1
Conditions
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Laryngeal Neoplasms
3
Thyroid Neoplasms
1
Stomatitis
1
Papilloma
1
Lymphatic Metastasis
1
Laryngeal papillomatosis
1
Hematologic Neoplasms
1
Carcinoma, Medullary
1
Cancer Pain
1
Interventions
trametinib
2
pertuzumab
2
dabrafenib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
sapanisertib
1
romidepsin
1
relatlimab
1
palbociclib
1
osimertinib
1
omipalisib
1
margetuximab
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
copanlisib
1
cobimetinib
1
cc-486
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vemurafenib
1
Sunitinib
1
Specimen Handling
1
Palliative Care
1
PF-05280014
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Laser Therapy
×
Head & Neck
×
Clear all
NCT07069153
2025-11-17
LOMUC
University of Pavia
Phase NA
Completed
40 enrolled